Home › Funds › Millennium Management › EGRX

Millennium Management position in EGRX

EAGLE PHARMACEUTICALS INC

Latest position (Q2 2024)167.78K sh
Reported value held$939.58K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 13.75K $767.00K New
Q4 2021 12.85K $654.00K Reduce
Q1 2022 12.45K $616.00K Reduce
Q2 2022 314.74K $13.98M Add
Q3 2022 164.64K $4.35M Reduce
Q4 2022 89.50K $2.62K Reduce
Q1 2023 297.47K $8.44K Add
Q2 2023 281.75K $5.48M Reduce
Q3 2023 347.53K $5.48M Add
Q4 2023 522.40K $2.73M Add
Q1 2024 257.86K $1.35M Reduce
Q2 2024 167.78K $939.58K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding EGRX

No other tracked fund reports a position in EGRX.

All EGRX fund holders →